Shelton Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-67,416
| Closed | -$6.69M | – | 892 |
|
|
2019
Q3 | $6.69M | Sell |
67,416
-7,429
| -10% | -$706K | 0.4% | 58 |
|
|
2019
Q2 | $6.92M | Buy |
74,845
+67,741
| +954% | +$6.43M | 0.4% | 58 |
|
|
2019
Q1 | $75.3K | Sell |
7,104
-68,217
| -91% | -$5.97M | 0.3% | 70 |
|
|
2018
Q4 | $4.83M | Sell |
75,321
-5,357
| -7% | -$395K | 0.33% | 68 |
|
|
2018
Q3 | $7.22M | Sell |
80,678
-18,237
| -18% | -$1.61M | 0.41% | 53 |
|
|
2018
Q2 | $7.86M | Buy |
98,915
+137
| +0.1% | +$11.4K | 0.49% | 42 |
|
|
2018
Q1 | $8.81M | Buy |
98,778
+6,860
| +7% | +$659K | 0.58% | 35 |
|
|
2017
Q4 | $9.59M | Sell |
91,918
-540
| -0.6% | -$60.9K | 0.62% | 33 |
|
|
2017
Q3 | $13.5M | Sell |
92,458
-9,615
| -9% | -$1.31M | 0.91% | 17 |
|
|
2017
Q2 | $13.3M | Buy |
102,073
+6,766
| +7% | +$829K | 0.94% | 18 |
|
|
2017
Q1 | $11.9M | Buy |
95,307
+5,313
| +6% | +$636K | 0.82% | 18 |
|
|
2016
Q4 | $10.4M | Sell |
89,994
-375
| -0.4% | -$41.8K | 0.79% | 19 |
|
|
2016
Q3 | $9.45M | Buy |
90,369
+1
| +0% | +$108 | 0.79% | 21 |
|
|
2016
Q2 | $8.91M | Buy |
90,368
+2,200
| +2% | +$228K | 0.79% | 21 |
|
|
2016
Q1 | $8.82M | Buy |
88,168
+2,721
| +3% | +$280K | 0.8% | 20 |
|
|
2015
Q4 | $10.2M | Buy |
85,447
+540
| +0.6% | +$62.5K | 0.99% | 17 |
|
|
2015
Q3 | $9.18M | Buy |
84,907
+3,334
| +4% | +$414K | 1.01% | 14 |
|
|
2015
Q2 | $9.44M | Buy |
81,573
+3,099
| +4% | +$354K | 0.98% | 17 |
|
|
2015
Q1 | $9.05M | Buy |
78,474
+6,276
| +9% | +$750K | 0.98% | 15 |
|
|
2014
Q4 | $8.08M | Buy |
72,198
+7,022
| +11% | +$741K | 0.94% | 15 |
|
|
2014
Q3 | $6.18M | Buy |
65,176
+3,556
| +6% | +$321K | 0.83% | 17 |
|
|
2014
Q2 | $5.29M | Buy |
61,620
+1,036
| +2% | +$78.8K | 0.74% | 19 |
|
|
2014
Q1 | $4.23M | Buy |
60,584
+2,420
| +4% | +$192K | 0.62% | 26 |
|
|
2013
Q4 | $4.91M | Sell |
58,164
-20,092
| -26% | -$1.59M | 0.74% | 19 |
|
|
2013
Q3 | $6.02M | Sell |
78,256
-42
| -0.1% | -$2.94K | 1.01% | 11 |
|
|
2013
Q2 | $4.58M | Buy |
+78,298
| New | +$4.71M | 0.84% | 19 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Shelton Capital Management's CELG Position: Q4 2019 in Review
Shelton Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 67,416 shares — an estimated $6.69M sold.
Shelton Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $13.5M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Shelton Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Shelton Capital Management sold 67,416 Celgene Corp shares in Q4 2019, an estimated $6.69M.
- Shelton Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Shelton Capital Management's Celgene Corp position peaked at $13.5M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Shelton Capital Management's 13F filing for Q4 2019, filed 11 Feb 2020.